Book a Consultation
(562) 702-3825
(562) 702-3825
In the medical field, MOHS surgery has been the traditional method of treating skin cancer for many years. However, with the recent advancement in medical technology, individuals with basal or squamous cell skin cancers can now opt for a new and innovative treatment option. This treatment is known as SRT, and it works exceptionally well in treating skin cancer without requiring any form of surgery. It is remarkable because it incorporates highly focused radiation to target and destroy cancer cells, which reduces any possible damage to surrounding healthy tissue. With this targeted approach, SRT ensures that cancer treatment is successful, while at the same time keeping the patient comfortable. Furthermore, individuals who choose this treatment option avoid the discomfort, scarring, and prolonged recovery time associated with surgery. Therefore, SRT serves as an effective, safe, and non-invasive option that allows individuals to resume their daily activities quickly and without any difficulty. All in all, anyone with basal or squamous cell skin cancer should consider SRT as a desirable treatment option over a surgical procedure.
Superficial Radiation Therapy, or SRT, targets and attacks non-melanoma skin cancer cells at the source without cutting the skin. Furthermore, there is no downtime and patients can return to their everyday lives right after treatment!
SRT skin cancer treatment can remove lesions on the arms, legs, back, and trunk, and it is especially efficient in treating skin cancers on the face, head and neck. It can deliver a controlled dose of Radiation to delicate areas that are hard to treat, such as those along the fold of the nose, eyelids, lips, corner of the mouth and lining of the ear. Superficial Radiation Therapy is also highly effective in the treatment of keloid after surgery.
The skin cancer is removed from the skin in a surgical procedure involving cutting, creating a wound and ultimately a scar.
Uses SRT technology to penetrate beneath the skin directly into the cancer, shrinking the tumor and over several treatments, curing it.
Surgery and cutting is the only way of knowing the size and depth of the skin cancer.
No Anesthesia necessary
Local anesthesia is needed to dull the pain prior to cutting the skin.
Short treatment sessions performed over the course of several weeks.
Local anesthesia is needed to dull the pain prior to cutting the skin.
Local anesthesia is needed to dull the pain prior to cutting the skin.
You can resume daily activities immediately as there is no bleeding or wounds from surgery.
Daily activities and showering are put on hold while the wound heals. The wound also requires constant care including bandage and dressing changes.
No scarring.
Reconstructive surgery may be necessary to correct scarring and deformities.
One or more skin cancer locations can be treated during the same session.
Only a single location can be treated in a session.
SRT cures over 98% of Basal and Squamous cell skin cancers.
On average MOHS works 96% to 98% of the time and may require additional surgery.
Covered by Medicare and Supplemental Insurance.
Covered by Medicare and Supplemental Insurance.
Can be performed on-location in the mobile MSS clinic.
Must be performed in a sterile surgical setting to avoid infection.
No risk of surgical infections.
Risk of serious infection during and after procedure.